MARKET

ODT

ODT

Odonate Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.510
-0.100
-2.77%
Opening 14:24 06/18 EDT
OPEN
3.630
PREV CLOSE
3.610
HIGH
3.680
LOW
3.510
VOLUME
240.47K
TURNOVER
--
52 WEEK HIGH
44.29
52 WEEK LOW
2.800
MARKET CAP
135.16M
P/E (TTM)
-0.9271
1D
5D
1M
3M
1Y
5Y
Do Institutions Own Odonate Therapeutics, Inc. (NASDAQ:ODT) Shares?
Every investor in Odonate Therapeutics, Inc. ( NASDAQ:ODT ) should be aware of the most powerful shareholder groups...
Simply Wall St. · 06/07 11:09
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Benzinga · 06/04 20:38
Aerpio Pharmaceuticals, Apellis Pharmaceuticals leads healthcare gainers; Shineco, Seelos Therapeutics among major losers
Gainers: Aerpio Pharmaceuticals ARPO +61%, Apellis Pharmaceuticals (APLS) +21%, Petros Pharmaceuticals PTPI +19%, Odonate Therapeutics (ODT) +11%, AbCellera Biologics (ABCL) +9%.Losers: Shineco (TYHT) -19%, Seelos Therapeutics SEEL -18%, CEL-SCI (CVM) -11%...
Seekingalpha · 05/17 15:02
Sabby Management, Llc Buys Sorrento Therapeutics Inc, Second Sight Medical Products Inc, ...
GuruFocus News · 05/17 10:38
Odonate Therapeutics EPS misses by $0.05
Odonate Therapeutics (ODT): Q1 GAAP EPS of -$0.90 misses by $0.05.Cash of $133.2MPress Release
Seekingalpha · 05/14 12:53
BRIEF-Odonate Therapeutics - Qtrly Loss Per Share Of $0.90
reuters.com · 05/14 12:46
Odonate Therapeutics Q1 EPS $(0.90) Up From $(0.99) YoY
Odonate Therapeutics (NASDAQ:ODT) reported quarterly losses of $(0.90) per share. This is a 9.09 percent increase over losses of $(0.99) per share from the same period last year.
Benzinga · 05/14 12:38
Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021
Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021.
Business Wire · 05/14 12:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ODT. Analyze the recent business situations of Odonate Therapeutics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ODT stock price target is 3.667 with a high estimate of 4.000 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 121
Institutional Holdings: 32.96M
% Owned: 85.58%
Shares Outstanding: 38.51M
TypeInstitutionsShares
Increased
25
2.06M
New
23
3.40M
Decreased
23
993.76K
Sold Out
34
10.20M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.18%
Pharmaceuticals & Medical Research
-1.11%
Key Executives
Chairman/Chief Executive Officer/Director
Kevin Tang
Chairman/Chief Executive Officer/Director
kevin Tang
Chief Financial Officer
Michael Hearne
Other
Joseph O'Connell
Other
Joseph O'connell
Director
Robert Rosen
Independent Director
Aaron Davis
Independent Director
Laura Douglass
Independent Director
Craig Johnson
No Data
About ODT
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

Webull offers kinds of Odonate Therapeutics Inc stock information, including NASDAQ:ODT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ODT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ODT stock methods without spending real money on the virtual paper trading platform.